Affibody-conjugated 5-fluorouracil prodrug system preferentially targets and inhibits HER2-expressing cancer cells

Journal

Biochemical and Biophysical Research Communications

Journal Volume

582

Pages

137-143

Date Issued

2021

Author(s)

Tsai C.-L.

Chen Y.-Y.

Lee T.-L.

Pai C.-W.

Chao Y.

Lan K.-L.

DOI

10.1016/j.bbrc.2021.09.078

URI

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117851199&doi=10.1016%2fj.bbrc.2021.09.078&partnerID=40&md5=c171227c3555a7c2d676bfd55dd0c2c4

https://scholars.lib.ntu.edu.tw/handle/123456789/608088

SDGs

[SDGs]SDG3

Publisher

Elsevier B.V.

Type

journal article